Brooks Laboratories Limited — Board Meeting, 06-02-2026: Outcome of Board Meeting

Brooks Labs Board approved financial results for Q3 and nine months ended Dec 2025. Consolidated net profit for Q3 was ₹5.50 Cr and ₹23.06 Cr for 9 months. The planned alteration of the company's Object Clause did not take effect as regulatory approval was denied.